Table 3: Posttreatment transcript levels (ΔCT) for subjects with MDD (N=22) and sex-, age-, race-matched ND controls (N=22)

From: Blood transcriptomic biomarkers in adult primary care patients with major depressive disorder undergoing cognitive behavioral therapy

GeneMDD mean (s.d.)CONTROL mean (s.d.)P-valueqCohen’s D
ADCY320.25 (1.85)20.44 (1.96)0.0920.1900.357
AMFR19.33 (0.75)19.33 (0.47)0.9130.9130.004
ASAH115.98 (2.15)16.04 (2.13)0.6800.7160.065
ATP11C18.78 (2.13)18.48 (2.11)0.1230.2080.363
CD5920.09 (0.67)19.79 (0.74)0.1250.2080.355
CDR220.68 (1.23)20.46 (0.66)0.3760.4700.215
CMAS22.55 (1.04)23.04 (0.70)0.0760.1900.481
DGKA16.33 (0.72)17.40 (0.89)<0.0010.0050.883
FAM46A18.84 (2.18)19.04 (2.22)0.2320.3310.309
IGSF4A/CADM121.50 (2.48)22.19 (2.48)0.0010.0050.862
KIAA153918.15 (0.62)18.71 (0.50)<0.0010.0050.840
MAF21.16 (2.11)21.10 (2.33)0.5550.6530.026
MARCKS16.22 (1.82)16.64 (2.12)0.0100.0400.558
NAGA16.89 (2.15)16.99 (2.14)0.5950.6610.119
PSME117.04 (0.68)17.46 (0.56)0.0330.0940.533
PTP4A320.79 (0.74)21.05 (0.64)0.1630.2510.339
RAPH121.45 (1.07)22.86 (0.60)<0.0010.0051.086
SLC4A117.02 (1.16)17.37 (0.80)0.0950.1900.290
TLR718.52 (2.24)18.92 (2.09)0.0160.5330.550
ZNF29122.48 (3.12)21.95 (2.96)0.3730.4700.249
  1. Abbreviations: MDD, major depressive disorder; ND, nondepressed. Bold entries represent significant results.